The university resumed limited study abroad in January 2022. In the intervening eighteen months, the university has resumed full study abroad operations. Consequently, the impact of these changes is likely minimal.
However, COVID-19 remains a risk to travelers. While we are more accustomed to the risks and inconveniences of COVID-19, the risks remain. These can range from the imposition of social distancing and masking to isolation resulting from symptomatic and asymptomatic infection. Although not required at this time by the University of Illinois, vaccination and periodic boosters are encouraged to reduce risk while traveling.
Countries retain their authority to treat COVID-19 as a health emergency, to include imposing strict mitigation measures (altering entry requirements, vaccinations, testing, etc.) at any time. Travelers should review country information before and during travel.
A few international programs may still require proof of vaccination for participation. These programs will be identified during student advising for study abroad. Without disclosing vaccination status, students unable to vaccinate for medical or religious reasons should coordinate with study abroad advisers to identify other potential programs.